IL18 and primary cutaneous T-cell non-Hodgkin lymphoma: It can, therefore, be hypothesized that in the case of CTCL, high IL-18 levels in combination with almost absent IL-12 can favor the skewing of CD4+ T-cells to the Th2 phenotype, which, in turn, can give rise to the malignant clone.